Tissue Engineering Market Size to Surpass US$ 31.16 Billion by 2030 - Growth Plus Reports

Pune, Nov. 21, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Tissue Engineering Market by Material Type (Biologically Derived Material, Synthetic Material, and Others), by Application (Neurology, Orthopedic, Musculoskeletal & Spine, Cardiology & Vascular, Skin & Integumentary, Urology, Dental, Cord Blood & Cell banking, Cancer, and Gynecology) – Global Outlook & Forecast 2022-2030" published by Growth Plus Reports, the Tissue Engineering Market is expected to grow at a CAGR of 10.45% from 2021 to reach US$ 31.16 billion by 2030.

Download Sample PDF Brochure of Tissue Engineering Market:


Market Drivers

Technological advancements in one of the major factors influencing the market growth. For instance, tissue engineering supplied a way for innovation of novel regenerative medicine techniques and disease simulation models. The application of organ-on-a-chip, induced pluripotent stem cell, and three-dimensional bioprinting technologies is among the most significant recent advancements of tissue engineering. The success of tissue engineering and its application to regenerative medicine will be influenced by these technologies. Continued investment in tissue engineering will produce goods and medicines that are both useful commercially and effective in preventing disease.

Excerpts from ‘By Material Type’

Based on material type, the market is grouped into

  • Biologically Derived Material
  • Synthetic Material
  • Others

Biologically derived materials are used in tissue engineering technique. Mechanical support offered by naturally occurring materials are influencing the segment growth. Additionally, biologically derived materials are best suited in production of newly formed tissues which resembles vital organs. Synthetic materials are expected to grow with high CAGR in forecast period as it offers high mechanical support to carrier scaffolds.

Excerpts from ‘By Application’

According to application, the global tissue engineering market is segmented into

  • Neurology
  • Orthopedic
  • Musculoskeletal & Spine
  • Cardiology & Vascular
  • Skin & Integumentary
  • Urology
  • Dental
  • Cord Blood & Cell Banking
  • Cancer
  • Gynecology

The orthopedic segment holds majority of market share. Whereas skin & integumentary segment is expected to register high growth in the projected period. Tissue engineering in orthopedic segment promotes functional constructions that repair, maintain, or enhance organs or damaged tissues. Artificial skin and cartilage are two examples of synthetic tissues that have received FDA approval.

Excerpts from ‘By Region’

Geographically, global tissue engineering market has been segmented into

  • North America
  • Europe
  • Asia Pacific
  • The Rest of The World

North America holds majority of market share followed by Europe and Asia Pacific. The factors influencing the growth of North America are increased support of government, increased use of tissue engineering models in research and development domain. The European region holds second position in the global market. This is characterized by factors such as presence of many market players in the region, increased research activities in life sciences. Furthermore, high prevalence of chronic diseases such as cardiac disorders and cancer are also influencing the growth of market in this region. Asia Pacific region is expected to grow with a high CAGR in the projected period due to increasing healthcare standards. Furthermore, increased research and development on regenerative medicines mostly in countries such as Iran, South Korea are supporting the market growth in Asia Pacific.

Excerpts from ‘Competitive Landscape’

Some of the prominent players operating in the global tissue engineering market are

  • Medtronic Plc
  • Allergan Plc
  • Zimmer Biomet Holdings, Inc.
  • Athersys, Inc.
  • Acell, Inc.
  • Stryker Corporation Organogenesis Holdings Inc.
  • Reprocell, Inc.
  • Rti Surgical, Inc.
  • Baxter International, Inc.
  • Integra Lifesciences Corporation
  • Tissue Regenix Group Plc

Inquire Before Buying This Research Report:


Table of Content

    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
    1.    Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
    1. Drivers
    2. Restraints
    3. Opportunities
    1. Biologically Derived Material 
    2. Synthetic Material 
    3. Others
    1. Neurology
    2. Orthopedic 
    3. Musculoskeletal & Spine 
    4. Cardiology & Vascular 
    5. Skin & Integumentary 
    6. Urology 
    7. Dental
    8. Cord Blood & Cell banking 
    9. Cancer
    10. Gynaecology

TOC Continue…

Scope of the Report:

Report AttributeDetails
Market size value in 2021US$ 12.74 billion
Revenue forecast in 2030US$ 31.16 billion
Growth RateCAGR of 10.45% from 2022 to 2030
Base year for estimation2021
Forecast period2022-2030
Segments coveredby material type, application, and region.
Regional scopeNorth America, Europe, Asia Pacific, and the Rest of the World (ROW)


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market


  • Distributor Landscape Assessment
  • Pipeline Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • 'Business Profile' of Key Players

Quickly Purchase Premium Copy of Tissue Engineering Market Report:


About Us        

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

 Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.


Contact Data